These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6991356)

  • 21. Renin, angiotensin II and juxtaglomerular apparatus in liver cirrhosis.
    Kondo K; Nakamura R; Saito I; Saruta T; Matsuki S
    Jpn Circ J; 1974 Oct; 38(10):913-21. PubMed ID: 4371275
    [No Abstract]   [Full Text] [Related]  

  • 22. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical assessment of electrolyte metabolism and the renin-aldosterone system in patients with liver cirrhosis and ascites].
    Mansurov KhKh; Dustov AD; Nikolaeva OS
    Ter Arkh; 1989; 61(11):54-7. PubMed ID: 2699096
    [No Abstract]   [Full Text] [Related]  

  • 24. [Increase in absolute atmospheric pressure in hyperbaric chamber in cirrhosis with ascites: lack of natriuretic response and increase of atrial natriuretic peptide].
    Gambini G; Fioroni E; Guerra M; Moscatelli A; Valori C
    Minerva Med; 1994 Mar; 85(3):77-81. PubMed ID: 8196847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.
    Vila MC; Coll S; Solà R; Andreu M; Gana J; Marquez J
    Am J Gastroenterol; 1999 Aug; 94(8):2219-23. PubMed ID: 10445553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of renin and substrate concentrations in human serum.
    Gould AB; Skeggs LT; Kahn JR
    Lab Invest; 1966 Nov; 15(11):1802-13. PubMed ID: 4288919
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pathogenesis and therapy of edematous diseases. 1. Pathogenesis of edematous diseases].
    Werning C
    Fortschr Med; 1977 Jul; 95(26):1677-84. PubMed ID: 885455
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radioimmunologic determination of renin, angiotensin and aldosterone; its clinical significance].
    Abdelhamid S; Walb D; Vecsei P
    Med Welt; 1976 Oct; 27(42):2008-13. PubMed ID: 994811
    [No Abstract]   [Full Text] [Related]  

  • 31. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis.
    Sansoé G; Silvano S; Mengozzi G; Todros L; Smedile A; Touscoz G; Rosina F; Rizzetto M
    J Hepatol; 2004 Mar; 40(3):417-23. PubMed ID: 15123355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurements of renin-angiotensin-aldosterone.
    Poulsen K
    Pharmacol Rev; 1973 Jun; 25(2):249-57. PubMed ID: 4354167
    [No Abstract]   [Full Text] [Related]  

  • 33. [Plasma aldosterone in compensated liver cirrhosis].
    Hirano Y; Ichikawa S
    Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):467-73. PubMed ID: 6088653
    [No Abstract]   [Full Text] [Related]  

  • 34. Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis.
    Bernardi M; Rimondi A; Gasbarrini A; Trevisani F; Caraceni P; Legnani C; Palareti G; Gasbarrini G
    J Hepatol; 1994 Feb; 20(2):289-95. PubMed ID: 8006409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of the enzyme systems in plasma renin activity measurement by angiotensin I radioimmunoassay.
    Zucchelli GC; Malvano R; Rosa U; Salvetti A
    J Nucl Biol Med; 1973; 17(4):187-95. PubMed ID: 4361186
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin, aldosterone, urinary sodium and weight change in cirrhotic patients with ascites and sodium restriction.
    Rocha MP; Gorjão R; Garcia D; Siqueira C; Faro L; Pinto Correia J
    Acta Med Port; 1986; 7(4):157-60. PubMed ID: 3548223
    [No Abstract]   [Full Text] [Related]  

  • 38. [The renin-angiotensin-aldosterone system under stimulation conditions after kidney transplantation].
    Küppers H; Banzhaf R; Schnurr E
    Med Welt; 1981 Jul; 32(29):1141-2. PubMed ID: 7022102
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of the cirrhotic liver to inactivate renin: evidence for a splanchnic source of renin-like activity.
    Barnardo DE; Strong CG; Baldus WP
    J Lab Clin Med; 1969 Sep; 74(3):495-506. PubMed ID: 4308911
    [No Abstract]   [Full Text] [Related]  

  • 40. [Renin-angiotensin-aldosterone system in patients with Itsenko-Cushing syndrome treated with chloditane and large doses of reserpine].
    Slavnov VN; Iakovlev AA; Komissarenko IV; Cheban AK; Rybakov SI
    Ter Arkh; 1980; 52(8):40-3. PubMed ID: 7020145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.